Rho(d) Immune Globulin - Histology

Relevant Publications

Guide to Rho(D) Immune Globulin in Women With Molecularly Defined Asian-type DEL (c.1227G>A).

Issue Release: 2024

Guideline No. 448: Prevention of Rh D Alloimmunization.

Issue Release: 2024

Society for Maternal-Fetal Medicine Statement: RhD immune globulin after spontaneous or induced abortion less than 12 weeks of gestation.

Issue Release: 2024

Prenatal Care: An Evidence-Based Approach.

Issue Release: 2023

A Case of Massive Fetal-Maternal Hemorrhage: Lessons Learned in Diagnosis and Treatment.

Issue Release: 2022

RHD genotyping is recommended for all patients with serological weak-D phenotypes in Asian populations - Cases with coexistence of weak-D and Asia type DEL alleles results in complete expression of D-antigen.

Issue Release: 2020

No. 133-Prevention of Rh Alloimmunization.

Issue Release: 2018

Misleading hepatitis B serology following Rho (D) immune globulin (human) injection and influenza vaccine.

Issue Release: 2018

High dose Intravenous Anti-D Immune Globulin is More Effective and Safe in Indian Paediatric Patients of Immune Thrombocytopenic Purpura.

Issue Release: 2016

Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag.

Issue Release: 2015

Potential drug interaction between Rho(D) immune globulin and live virus vaccine.

Issue Release: 2014

Update on prenatal care.

Issue Release: 2014

Rituximab for the treatment of acute refractory ITP.

Issue Release: 2014

Dermatofibrosarcoma protuberans arising at a Rho(D) immune globulin injection site.

Issue Release: 2012

Trends in anti-D immune globulin for childhood immune thrombocytopenia: usage, response rates, and adverse effects.

Issue Release: 2011

Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multi-center assessment.

Issue Release: 2008

Rapid encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.

Issue Release: 2008

A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness.

Issue Release: 2007

A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders.

Issue Release: 2007

A prospective study of thimerosal-containing Rho(D)-immune globulin administration as a risk factor for autistic disorders.

Issue Release: 2007

What is the Role of Acetylcholine?

How Does Staining Aid Diagnosis?

How Can Formalin Pigment Be Removed?

How is IFT Relevant to Histology?

What are the Functions of Dopamine?

What are the Risks and Benefits?

What are Common Problems Related to Brightness?

What is Osteosarcoma?

What is a Conoid?

Why Are Transitional Zones Important?

Partnered Content Networks

Relevant Topics